Login
|
Register
|
Email Alerts
Home
PTV Guide
PTV Channel
PV Business Review
PDeals Commentaries
The Business Report
The Regional Report
The Financial Report
Focus on Australia
Register
About PTV
About PTV
Advertise
Sponsor PTV
The Right Package
Reach Our Audience
Contact Us
PV Business Review
PDeals Commentaries
The Business Report
The Regional Report
The Financial Report
Focus on Australia
PV Business Review
PharmaTelevision interviews top executives from leading pharmaceutical and biotechnology companies. Sponsored by
PharmaVentures
Experts in Deals and Alliances.
Alphabetical order
|
Date order
Bristol-Myers
Biota Focuses on
Starpharma’s
Merck Goes Back to
Roche Seeks Out CNS
Pfizer’s Investment
Takeda Strengthens
How Do Eli Lilly &
Oxford BioMedica:
Sir Michael Rawlins
Early Stage Spin
Novacta Biosystems:
Recent Deals
Cancer Research
PharmaVentures:
DuBiotech: The
Antisoma Plc
InterMed Discovery:
EGEN: A Research
Cellzome and
Xceleron: Changing
Polyphor Ltd:
Stemgent: Supplying
EBD Group: Carola
Artisan Draws
La Jolla
Paul Capital
BioInvent’s Deal
EuropaBio: Working
BIO: The Future
Neuropharma: A New
Karus Therapeutics:
ValiRx: Bioscience
Mercury
AM-Pharma:
The GI Company:
Takeda Research
Maryland DBED: Will
Addex
Apposite Capital:
Archimedes Pharma:
EUSA Pharma:
Bird & Bird: A View
Synta
Novarix: Interview
NovaQuest:
London Genetics:
Xanthus: Evolving
Uniseed Management
Tissue Therapies’
Speedel’s Renin
Micromet: From
BayBio: Impact of
AusBiotech: An
Ablynx’s Success
Alchemia: Drug
Stem Cell Sciences:
Phylogica: Business
Merck & Co.:
KaloBios: The
IEDC: Indiana: A
GE Healthcare
MorphoSys:
McKenna Long &
eG Capital:
Simmons & Simmons:
Johnson & Johnson:
Bristol-Myers
Sofinnova Partners:
Piramed Pharma: The
Ganymed Pharma:
Faust
Eli Lilly & Co.:
Oxford Technology
PharmaDeals
Novosom: Strategies
BIOCOM: Challenges
Midatech: The Story